You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

radium-223

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biochemical Recurrent Prostate Cancer Trial run by the National Cancer Institute (NCI) (Radium-223, 18F Sodium Fluoride)

Recruiting
  • Biochemical Recurrent Prostate Cancer
  • Radium-223
  • 18F Sodium Fluoride
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

Not yet recruiting
  • Metastatic Prostate Cancer
  • (no location specified)
Mar 6, 2023

Prostate Cancer Trial in Boston (Radium-223, Pembrolizumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 31, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Lutetium-177 PSMA-I&T
  • Radium-223
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

Prostate Cancer Trial in Baltimore (Radium-223, stereotactic ablative radiotherapy (SABR))

Recruiting
  • Prostate Cancer
  • Radium-223
  • stereotactic ablative radiotherapy (SABR)
  • Baltimore, Maryland
    Johns Hopkins
May 25, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Stage IVB Prostate Cancer AJCC v8 Trial in San

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Radium-223
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 20, 2023

Metastatic Prostate Cancer, Pain Trial in New York, Chapel Hill (Radium-223)

Completed
  • Metastatic Prostate Cancer
  • Pain
  • Radium-223
  • New York, New York
  • +2 more
Feb 3, 2022

Metastatic Prostate Cancer in Pirkanmaa Hospital District in

Not yet recruiting
  • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 17, 2023

Prostate Cancer Trial in United States (Radium-223, Sipuleucel-T)

Completed
Has Results
  • Prostate Cancer
  • Radium-223
  • Sipuleucel-T
  • Los Angeles, California
  • +4 more
Jun 15, 2021

Health-related Quality of Life, Psychological Distress and

Completed
  • Castrate Resistant Prostate Cancer
  • Bone Metastases
  • Radium-223
  • 's-Hertogenbosch, Netherlands
  • +10 more
Jul 29, 2021

Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)

Recruiting
  • Prostate Cancer
  • Docetaxel 75 mg/m2
  • +2 more
  • Gilbert, Arizona
  • +52 more
Feb 2, 2023

Prostate Cancer Trial in Spain (radium-223)

Completed
  • Prostate Cancer
  • radium-223
  • Barcelona, Spain
  • +5 more
Nov 25, 2020

Metastatic Renal Cell Carcinoma Trial in Boston (Pazopanib, Sorafenib, Radium-223)

Completed
  • Metastatic Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
Mar 3, 2020

Metastatic Castration-resistant Prostate Cancer Trial in Italy (Radium-223, Docetaxel)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Meldola, FC, Italy
  • +11 more
Apr 20, 2020

Urothelial Carcinoma Trial in Ann Arbor (Atezolizumab, Radium-223)

Terminated
  • Urothelial Carcinoma
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Oct 22, 2018